Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions

Control of societal costs can be addressed through clinician education, value‐based guidelines and pathways, formulary restrictions, payment reform, and government regulatory decisions but should not be imposed on patients at the point of decision‐making in the cancer clinic.